Everton donation helps five-year-old Sunderland fan reach £700,000 cancer treatment goal : independent

As it stated in independent

Everton donation helps five-year-old Sunderland fan reach £700,000 cancer treatment goal

Everton donation helps five-year-old Sunderland fan reach £700,000 cancer treatment goal

Sunderland-loving Bradley Lowery has achieved his goal of raising £700,000 for his cancer treatment after a boost from rivals Everton.Five-year-old Bradley led the Black Cats out alongside his hero Jermain Defoe on Monday night as Everton marched out 3-0 winners at the Stadium of Light.Bradley received a round of applause from the crowd in the fifth minute, with both sets of fans uniting in singing 'there's only one Bradley Lowery' and passing around a banner bearing a support message.Following the game, Everton pledged to donate £200,000 to the fundraising campaign and following the publicity Monday night's game gave to Bradley, he has now reached his target.


not to mention upi

Counting cancer cells in blood may show treatment is working

Counting cancer cells in blood may show treatment is working

LONDON, Sept. 14 (UPI) -- A blood test may be enough to determine if prostate cancer treatment is working, and allow doctors to change treatment faster if it isn't effective.A 30 percent drop in circulating tumor cells in blood samples can indicate the efficacy of prostate cancer treatment, researchers in England report in a new study published in the journal European Urology.Circulating tumor cells are cancer cells shedded by both primary and metastatic tumors, which can be detected in blood samples.The use of blood tests to diagnose and track cancer has garnered more attention in recent years, and CTCs have been indicated as potentially helping to determine prognosis of breast, colon and prostate cancers.


in addition marketwatch

Spectrum Pharmaceuticals' stock drops after cancer treatment voted down by FDA committee

Spectrum Pharmaceuticals' stock drops after cancer treatment voted down by FDA committee

Spectrum Pharmaceuticals Inc. SPPI, -7.83% said Wednesday that an Food and Drug Administration advisory committee voted that biotechnology company's cancer treatment, Qapzola, did not show substantial evidence of a treatment effect over placebo.The company said the FDA is not bound to follow the committee's recommendation, when it makes its final decision on Qapzola by Dec. 11.The stock dropped 5% in afternoon trade, but pared earlier losses of as much as 15%.The stock has now shed 14% year to date, while the SPDR S&P Biotech ETF XBI, +2.32% has lost 9.4% and the S&P 500 SPX, +0.01% has gained 4.4%.